{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:42:40Z","timestamp":1792201360613,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11102-026-01771-w","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:15:00Z","timestamp":1792199700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Help\u2014we need a psychiatrist!"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0618-6147","authenticated-orcid":false,"given":"Stephan","family":"Petersenn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"1771_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/EJE-18-0682","volume":"180","author":"AG Ioachimescu","year":"2019","unstructured":"Ioachimescu AG, Fleseriu M, Hoffman AR, Vaughan Iii TB, Katznelson L (2019) Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas. Eur J Endocrinol 180:31\u201340","journal-title":"Eur J Endocrinol"},{"key":"1771_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mds.29700","volume":"39","author":"I Debove","year":"2024","unstructured":"Debove I, Paschen S, Amstutz D, Cardoso F, Corvol J-C, Fung VSC, Lang AE, Martinez Martin P, Rodr\u00edguez-Oroz MC, Weintraub D, Krack P (2024) Deuschl,G., the Members of the ICBD in PD Management Consensus Group: Management of Impulse Control and Related Disorders in Parkinson\u2019s Disease: An Expert Consensus. Mov Disord 39:235\u2013248","journal-title":"Mov Disord"},{"key":"1771_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70777","author":"JY Goh","year":"2026","unstructured":"GohJY, Chan LG, Cardoso F, Tan LCS (2026) Clinical approach to impulse control-related behavioral disorders in parkinson\u2019s disease: a scoping review. Mov Disord Clin Pract Online ahead print. https:\/\/doi.org\/10.1002\/mdc3.70777","journal-title":"Mov Disord Clin Pract Online ahead print"},{"key":"1771_CR4","doi-asserted-by":"publisher","first-page":"e70264","DOI":"10.1111\/bcpt.70264","volume":"139","author":"M Wolfschlag","year":"2026","unstructured":"Wolfschlag M, Espa E, Hauer KO, Timpka J, Smith R, Odin P, Cenci MA, H\u00e5kansson A (2026) The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational Perspective. Basic Clin Pharmacol Toxicol 139:e70264","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1771_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11102-026-01662-0","volume":"29","author":"P G\u00f6kbulut","year":"2026","unstructured":"G\u00f6kbulut P, Nergiz H, T\u0131r\u0131\u015f HC, Ta\u015fkald\u0131ran I, G\u00f6kbulut V, Ku\u015fkonmaz \u015eM (2026) Decision-making and impulsivity in cabergoline-treated prolactinoma: findings from Iowa Gambling, Go\/No-Go, and barratt scales. Pituitary 29:80","journal-title":"Pituitary"},{"key":"1771_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11102-026-01728-z","volume":"29","author":"KB Daniel","year":"2026","unstructured":"Daniel KB, Glezer A, de Queiroz NL, Correa-Silva SR, Trentin MBF, Fujiwara MT, Benetti-Pinto CL, Kasuki L, Tavares LAG, do Ros\u00e1rio PWS, Garmes HM (2026) Increased impulsivity and higher odds of compulsive shopping among cabergoline-treated patients with prolactinoma: a case-control study. Pituitary 29:130","journal-title":"Pituitary"},{"key":"1771_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11102-026-01693-7","volume":"29","author":"L Zerbinati","year":"2026","unstructured":"Zerbinati L, Cristilli G, Valier B, Braccia F, Okai D, Toffanin T, Verrienti M, Giampietro A, Grassi L, Zatelli MC, Ambrosio MR (2026) Impulse control disorders and their relationship with psychopathology in patients treated with cabergoline for hyperprolactinaemia. Pituitary 29:87","journal-title":"Pituitary"},{"key":"1771_CR8","doi-asserted-by":"publisher","first-page":"102104","DOI":"10.1016\/j.beem.2026.102104","volume":"40","author":"R Hamblin","year":"2026","unstructured":"Hamblin R, Ntali G, Karavitaki N (2026) Impulse control disorders and dopamine agonists. Best Pract Res Clin Endocrinol Metab 40:102104","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1771_CR9","doi-asserted-by":"publisher","first-page":"101356","DOI":"10.1016\/j.ghir.2020.101356","volume":"55","author":"HM Ozkaya","year":"2020","unstructured":"Ozkaya HM, Sahin S, Korkmaz OP, Durcan E, Sahin HR, Celik E, Poyraz BC, Kadioglu P (2020) Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas. Growth Horm IGF Res 55:101356","journal-title":"Growth Horm IGF Res"},{"key":"1771_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/mds.27689","volume":"34","author":"AH Evans","year":"2019","unstructured":"Evans AH, Okai D, Weintraub D, Lim S-Y, O\u2019Sullivan SS, Voon V, Krack P, Sampaio C, Post B, Leentjens AFG, Martinez-Martin P, Stebbins GT, Goetz CG (2019) Schrag,A., Members of the International Parkinson and Movement Disorder Society (IPMDS) Rating Scales Review Committee: Scales to assess impulsive and compulsive behaviors in Parkinson\u2019s disease: Critique and recommendations. Mov Disord 34:791\u2013798","journal-title":"Mov Disord"},{"key":"1771_CR11","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1210\/clinem\/dgaf355","volume":"111","author":"VR van Trigt","year":"2025","unstructured":"van Trigt VR, Andela CD, Bakker LEH, Brama SCM, Schmidt LE, Sneekes FM, Zeelenberg MW, Huisman SD, Bauduin SEEC, Dekkers OM, Verstegen MJT, van Furth WR, Pelsma ICM, Biermasz NR (2025) Subtle Cognitive Impairments and Psychological Complaints in Patients With Prolactinoma Despite Biochemical Control. J Clin Endocrinol Metab 111:e9\u2013e22","journal-title":"J Clin Endocrinol Metab"},{"key":"1771_CR12","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1210\/clinem\/dgad545","volume":"109","author":"LJ Heneghan","year":"2024","unstructured":"Heneghan LJ, Tsang A, Dimino C, Khandji AG, Panigrahi SK, Page-Wilson G (2024) Ropinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability. J Clin Endocrinol Metab 109:e667\u2013e674","journal-title":"J Clin Endocrinol Metab"},{"key":"1771_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/bcp.13802","volume":"85","author":"S Liu","year":"2019","unstructured":"Liu S, Hu C, Peters J, Tsang A, Cremers S, Bies R, Page-Wilson G (2019) Pharmacokinetics and pharmacodynamics of ropinirole in patients with prolactinomas. Br J Clin Pharmacol 85:366\u2013376","journal-title":"Br J Clin Pharmacol"},{"key":"1771_CR14","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","volume":"174","author":"TJ Moore","year":"2014","unstructured":"Moore TJ, Glenmullen J, Mattison DR (2014) Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med 174:1930\u20131933","journal-title":"JAMA Intern Med"},{"key":"1771_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, Bronstein M, Chanson P, Fukuoka H, Gadelha M, Greenman Y, Gurnell M, Ho KKY, Honegger J, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Lodish M, Maiter D, Marcus HJ, McCormack A, Muir MM, Neggers CA, Pereira S, Pivonello AM, Post R, Samson KRGSR, Shimon SL, Spencer-Segal I, Vila J, Wass G, Melmed J (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19:722\u2013740","journal-title":"Nat Rev Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01771-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01771-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01771-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:15:01Z","timestamp":1792199701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01771-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1771"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01771-w","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2 October 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No funding received for preparation of this editorial.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"168"}}